Tag Archives: AZD3152

AstraZeneca Highlights Long-Acting Antibodies and Vaccines for At-Risk Individuals at IDWeek Conference

(IN BRIEF) AstraZeneca is set to present new data at the 12th annual IDWeek conference, emphasizing the role of long-acting antibodies and vaccines in safeguarding at-risk individuals from common infectious respiratory diseases. The company will share 15 abstracts, including oral … Read the full press release

AstraZeneca to Present Data on Vaccines and Immune Therapies Portfolio at ECCMID 2023

(IN BRIEF) AstraZeneca is set to present data on its Vaccines and Immune Therapies portfolio at the European Congress of Clinical Microbiology & Infectious Diseases. Among the data to be presented will be details on the progress of AstraZeneca’s Vaccines … Read the full press release